Nephro-Urology Monthly

Published by: Kowsar

Comparison of the Efficacy of Tacrolimus Versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy

Hamidreza Omrani 1 , Sima Golmohamadi 1 , * , Fateme Hichi 2 and Masoud Sadeghi 3
Authors Information
1 Nephrology and Urology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran
2 Department of Internal Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran
3 Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran
Article information
  • Nephro-Urology Monthly: January 2017, 9 (1); e42473
  • Published Online: November 14, 2016
  • Article Type: Research Article
  • Received: September 30, 2016
  • Accepted: November 6, 2016
  • DOI: 10.5812/numonthly.42473

To Cite: Omrani H, Golmohamadi S, Hichi F, Sadeghi M. Comparison of the Efficacy of Tacrolimus Versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy, Nephro-Urol Mon. 2017 ;9(1):e42473. doi: 10.5812/numonthly.42473.

Abstract
Copyright: Copyright © 2017, Nephro-Urology Monthly. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Tryggvason K, Pettersson E. Causes and consequences of proteinuria: the kidney filtration barrier and progressive renal failure. J Intern Med. 2003; 254(3): 216-24[PubMed]
  • 2. Chen Y, Schieppati A, Chen X, Cai G, Zamora J, Giuliano GA, et al. Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome. Cochrane Database Syst Rev. 2014; (10)[DOI][PubMed]
  • 3. Santosh T, Liu H, Liu B. Effect of tacrolimus in idiopathic membranous nephropathy: a meta-analysis. Chin Med J (Engl). 2014; 127(14): 2693-9[PubMed]
  • 4. Cattran DC, Alexopoulos E, Heering P, Hoyer PF, Johnston A, Meyrier A, et al. Cyclosporin in idiopathic glomerular disease associated with the nephrotic syndrome : workshop recommendations. Kidney Int. 2007; 72(12): 1429-47[DOI][PubMed]
  • 5. Yuan H, Liu N, Sun GD, Jia Y, Luo P, Miao LN. Effect of prolonged tacrolimus treatment in idiopathic membranous nephropathy with nephrotic syndrome. Pharmacology. 2013; 91(5-6): 259-66[DOI][PubMed]
  • 6. Tao JL, Liu LL, Wen YB, Gao RT, Li H, Li MX, et al. Cyclosporine treatment in idiopathic membranous nephropathy nephrotic syndrome in adults: a retrospective study spanning 15 years. Chin Med J (Engl). 2011; 124(21): 3490-4[PubMed]
  • 7. Cattran DC, Appel GB, Hebert LA, Hunsicker LG, Pohl MA, Hoy WE, et al. Cyclosporine in patients with steroid-resistant membranous nephropathy: a randomized trial. Kidney Int. 2001; 59(4): 1484-90[DOI][PubMed]
  • 8. Yao X, Chen H, Wang Q, Tang Z, Hu W, Yin G, et al. Cyclosporin A treatment for idiopathic membranous nephropathy. Chin Med J (Engl). 2001; 114(12): 1305-8[PubMed]
  • 9. Li X, Lv R, He Q, Li H, Du X, Lin W, et al. Early initiation of tacrolimus or cyclophosphamide therapy for idiopathic membranous nephropathy with severe proteinuria. J Nephrol. 2008; 21(4): 584-91[PubMed]
  • 10. Praga M, Barrio V, Juarez GF, Luno J, Grupo Espanol de Estudio de la Nefropatia M. Tacrolimus monotherapy in membranous nephropathy: a randomized controlled trial. Kidney Int. 2007; 71(9): 924-30[DOI][PubMed]
  • 11. Ballarin J, Poveda R, Ara J, Perez L, Calero F, Grinyo JM, et al. Treatment of idiopathic membranous nephropathy with the combination of steroids, tacrolimus and mycophenolate mofetil: results of a pilot study. Nephrol Dial Transplant. 2007; 22(11): 3196-201[DOI][PubMed]
  • 12. Chen M, Li H, Li XY, Lu FM, Ni ZH, Xu FF, et al. Tacrolimus combined with corticosteroids in treatment of nephrotic idiopathic membranous nephropathy: a multicenter randomized controlled trial. Am J Med Sci. 2010; 339(3): 233-8[DOI][PubMed]
  • 13. Li ZQ, Hu ML, Zhang C, Wang YM. Efficacy and safety of tacrolimus vs. cyclophosphamide for idiopathic membranous nephropathy: A meta-analysis of Chinese adults. J Huazhong Univ Sci Technolog Med Sci. 2015; 35(5): 623-8[DOI][PubMed]
  • 14. Caro J, Gutierrez-Solis E, Rojas-Rivera J, Agraz I, Ramos N, Rabasco C, et al. Predictors of response and relapse in patients with idiopathic membranous nephropathy treated with tacrolimus. Nephrol Dial Transplant. 2015; 30(3): 467-74[DOI][PubMed]
  • 15. Xu J, Zhang W, Xu Y, Shen P, Ren H, Wang W, et al. Tacrolimus combined with corticosteroids in idiopathic membranous nephropathy: a randomized, prospective, controlled trial. Contrib Nephrol. 2013; 181: 152-62[DOI][PubMed]
  • 16. Naumovic R, Jovanovic D, Pavlovic S, Stosovic M, Marinkovic J, Basta-Jovanovic G. Cyclosporine versus azathioprine therapy in high-risk idiopathic membranous nephropathy patients: A 3-year prospective study. Biomed Pharmacother. 2011; 65(2): 105-10[DOI][PubMed]
  • 17. Alexopoulos E, Papagianni A, Tsamelashvili M, Leontsini M, Memmos D. Induction and long-term treatment with cyclosporine in membranous nephropathy with the nephrotic syndrome. Nephrol Dial Transplant. 2006; 21(11): 3127-32[DOI][PubMed]
  • 18. du Buf-Vereijken PW, Branten AJ, Wetzels JF, Membranous Nephropathy Study G. Cytotoxic therapy for membranous nephropathy and renal insufficiency: improved renal survival but high relapse rate. Nephrol Dial Transplant. 2004; 19(5): 1142-8[DOI][PubMed]
  • 19. du Buf-Vereijken PW, Feith GW, Hollander D, Gerlag PG, Wirtz JJ, Noordzij TC, et al. Restrictive use of immunosuppressive treatment in patients with idiopathic membranous nephropathy: high renal survival in a large patient cohort. QJM. 2004; 97(6): 353-60[PubMed]
  • 20. Goumenos DS, Katopodis KP, Passadakis P, Vardaki E, Liakopoulos V, Dafnis E, et al. Corticosteroids and ciclosporin A in idiopathic membranous nephropathy: higher remission rates of nephrotic syndrome and less adverse reactions than after traditional treatment with cytotoxic drugs. Am J Nephrol. 2007; 27(3): 226-31[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader